QuickView for PPARG;jsessionid=332B4884C01ADF891B8DE0B96A34CA36;jsessionid=DC29E8506FCA8BED5A0AB453AFF7E391;jsessionid=8946B811E1E813BF33C120BCB17EF68A (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Adipose tissue subcutaneous
Omental adipose tissue
Adipose tissue
Colon mucosa
Mammary gland

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Subcutaneous fat disorder
Metabolic syndrome X
Bacteremia
Drug resistance to insulin
Drug resistance

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

GSK-J4
4-iodo-3-nitrobenzamide
2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide
UNC 669
GDC 0879

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

MIR188
PEX11A
PAX8
SIX1
Pparg

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Identification of Selective PPAR-γ Modulators by Combining Pharmacophore Modeling, Molecular Docking…
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent P…
Evidence Linking PPARG Genetic Variants with Periodontitis and Type 2 Diabetes Mellitus in a Brazili…
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding.
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for PPARG;jsessionid=332B4884C01ADF891B8DE0B96A34CA36;jsessionid=DC29E8506FCA8BED5A0AB453AFF7E391;jsessionid=8946B811E1E813BF33C120BCB17EF68A

Explore Clinical Trials Results